Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

1,2100 0,0000 (0,00%) A partir del 02:22PM EDT. Mercado abierto.

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Sector(es): Healthcare
Sector: Medical Distribution
Empleados a tiempo completo: 48.164

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Qiuhua Yang	Executive Chairman	N/A	N/A	1972
Mr. Bo Shen	President, CFO, Head of the Accounting Department & Executive Director	778,58k	N/A	1973
Mr. Yongzhong Li	VP & Executive Director	832,29k	N/A	1970
Mr. Ming Dong	Executive Director	N/A	N/A	1976
Mr. Tao Zhong	VP, Board Secretary & Joint Company Secretary	N/A	N/A	1972
Mr. Dongming Li	Vice President	N/A	N/A	1969
Ms. Shuai Shao	Vice President	N/A	N/A	1988
Dr. Shunjiang Yu	Chief Medical Officer	N/A	N/A	N/A
Ms. Pui Kiu Wong	Joint Company Secretary	N/A	N/A	N/A
Ying Ke	Director & General Manager of R&D Management Center	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Gobierno corporativo

El ISS Governance QualityScore de Shanghai Pharmaceuticals Holding Co., Ltd, a día 1 de mayo de 2024, es 8. Las puntuaciones base son Auditoría: 7; Tablero: 10; Derechos de los accionistas: 9; Compensación: 2.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.